The recent announcement from CVS Health about the closure of its clinical trials unit, initiated only two years ago during the COVID-19 pandemic, has ignited a flurry of speculation.
The FTC is preparing to block Amgen's acquisition of Horizon Therapeutics, marking a new effort by antitrust enforcers to prevent a merger of pharmaceutical companies.